CLDN4 and glioblastoma: The Ki67 staining results of the xenograft tumors showed that the Ki67 positive rate in the shCLDN4 + ITD-1 group was significantly reduced, suggesting that the CLDN4 knockdown can inhibit the progression of GBM tumors (Fig. 7E).